- Germany consults on new drug pricing mechanism
- Price cuts loom on latest pre-AMNOG call up
- Short studies controversially scupper Almirall's Eklira, says German HTA
- German HTA 'a success', says GBA; Industry disagrees
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.